News
Hosted on MSN10mon
Roche’s VENTANA CLDN18 assay gains CE mark - MSN
Roche has gained the Conformité Européenne (CE) mark of approval for its VENTANA CLDN18 (43-14A) RxDx assay to identify patients with gastric or gastroesophageal junction (GEJ) adenocarcinoma ...
Roche has gained the Conformité Européenne (CE) mark of approval for its VENTANA CLDN18 (43-14A) RxDx assay to identify patients with gastric or gastroesophageal junction (GEJ) adenocarcinoma ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback